This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Jul 13;355(2):203-4; author reply 203-5.

doi: 10.1056/NEJMc066260. Epub 2006 Jun 26.

Adverse cardiovascular effects of rofecoxib

Steven E Nissen

PMID: 16801355
DOI: 10.1056/NEJMc066260

Comment

Adverse cardiovascular effects of rofecoxib

Steven E Nissen. N Engl J Med. 2006.

. 2006 Jul 13;355(2):203-4; author reply 203-5.

doi: 10.1056/NEJMc066260. Epub 2006 Jun 26.

Author

Steven E Nissen

PMID: 16801355
DOI: 10.1056/NEJMc066260

No abstract available

PubMed Disclaimer

Comment on

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.
Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA; Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Bresalier RS, et al. N Engl J Med. 2005 Mar 17;352(11):1092-102. doi: 10.1056/NEJMoa050493. Epub 2005 Feb 15. N Engl J Med. 2005. PMID: 15713943 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.